HomeComparePTMEY vs MRK

PTMEY vs MRK: Dividend Comparison 2026

PTMEY yields 171.23% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTMEY wins by $9.5K in total portfolio value
10 years
PTMEY
PTMEY
● Live price
171.23%
Share price
$1.17
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$66.3K
Annual income
$56.31
Full PTMEY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PTMEY vs MRK

📍 PTMEY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTMEYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTMEY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTMEY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTMEY
Annual income on $10K today (after 15% tax)
$14,554.79/yr
After 10yr DRIP, annual income (after tax)
$47.86/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,280.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTMEY + MRK for your $10,000?

PTMEY: 50%MRK: 50%
100% MRK50/50100% PTMEY
Portfolio after 10yr
$61.5K
Annual income
$4,927.23/yr
Blended yield
8.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PTMEY
No analyst data
Altman Z
2.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTMEY buys
0
MRK buys
0
No recent congressional trades found for PTMEY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTMEYMRK
Forward yield171.23%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$66.3K$56.8K
Annual income after 10y$56.31$9,798.13
Total dividends collected$28.1K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTMEY vs MRK ($10,000, DRIP)

YearPTMEY PortfolioPTMEY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,262$8,561.64$11,206$366.19+$8.1KPTMEY
2$28,316$7,706.14$12,650$502.35+$15.7KPTMEY
3$35,592$5,293.74$14,407$694.19+$21.2KPTMEY
4$41,193$3,109.34$16,585$967.82+$24.6KPTMEY
5$45,758$1,681.60$19,342$1,363.89+$26.4KPTMEY
6$49,834$872.88$22,913$1,947.19+$26.9KPTMEY
7$53,766$444.22$27,662$2,823.89+$26.1KPTMEY
8$57,754$223.96$34,159$4,173.35+$23.6KPTMEY
9$61,909$112.42$43,337$6,308.80+$18.6KPTMEY
10$66,299$56.31$56,776$9,798.13+$9.5KPTMEY

PTMEY vs MRK: Complete Analysis 2026

PTMEYStock

PT. Media Nusantara Citra Tbk operates as a media company in Indonesia. It operates through Television, Radio, Print Media, Content, and Advertising Agency segments. The company owns and operates national free-to-air televisions (TV), such as RCTI TV station that offers a range of programs, including drama series, box office movies, sports events, talent search shows, reality and music shows, anniversary and awards programs, and infotainment programs; MNCTV, which offers family drama series, animation, sports programs, and various shows; GTV that focuses on animation, variety shows, reality shows, game shows, and talent search programs; and iNews TV, which focuses on sports and other factual programs, as well as offers content library and talent management services. It also operates StarPro, which provides an infotainment channel on pay-TV platforms; Okezone.com, IDXChannel.com, and Sindonews.com news portals that serve Indonesian readers; RCTI+, an entertainment app; iNews.id, a news portal comprising national and regional news; Celebrities.id, a portal around celebrities and lifestyle; sportstars.id; StarHits, a digital creator network; ROOV, a radio streaming website; and eTV Mall, which allows TV viewers to purchase e-vouchers from advertisements on a TV program. The company was founded in 1987 and is headquartered in Jakarta Pusat, Indonesia. PT. Media Nusantara Citra Tbk is a subsidiary of PT Global Mediacom Tbk.

Full PTMEY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PTMEY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTMEY vs SCHDPTMEY vs JEPIPTMEY vs OPTMEY vs KOPTMEY vs MAINPTMEY vs JNJPTMEY vs ABBVPTMEY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.